By the end of 2017, CTS has secured three source plasma partners and continues to seek additional partners in the plasma industry in order to continue to diversify CTS’s revenue stream.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...